6 research outputs found
VP 16-213 and cytosine-arabinoside combination chemotherapy for refractory acute lymphoblastic leukemia in adults
Chromosome behaviour in the male and female sex mother cells of wheat (Triticum aestivum
Linseed essential oil - source of lipids as active ingredients for pharmaceuticals and nutraceuticals
Linseed - also known as flaxseed - is known for its beneficial effects on animal
health attributed to its composition. Linseed comprises linoleic and ?-linolenic fatty acids,
various dietary fibers and lignans, which are beneficial to health because they reduce the risk
of cardiovascular diseases, as well as cancer, decreasing the levels of cholesterol and relaxing
the smooth muscle cells in arteries increasing the blood flow. Essential fatty acids from flax
participate in several metabolic processes of the cell, not only as structuring components of
the cell membrane but also as storage lipids. Flax, being considered a functional food, can be
consumed in a variety of ways, including seeds, oil or flour, contributing to basic nutrition.
Several formulations containing flax are available on the market in the form of e.g. capsules
and microencapsulated powders having potential as nutraceuticals. This paper revises the different
lipid classes found in flaxseeds and their genomics. It also discusses the beneficial effects
of flax and flaxseed oil and their biological advantages as ingredients in pharmaceuticals
and in nutraceuticals products.The authors wish to acknowledge the financial support from the Portuguese Science and Technology Foundation, Ministry of Science and Education (FCT/MEC) through national funds, and co-financed by FEDER, under the Partnership Agreement PT2020 for the project M-ERA-NET/0004/2015-PAIRED.info:eu-repo/semantics/publishedVersio
The clonal origin and clonal evolution of epithelial tumours
While the origin of tumours, whether from one cell or many, has been a source of fascination for experimental oncologists for some time, in recent years there has been a veritable explosion of information about the clonal architecture of tumours and their antecedents, stimulated, in the main, by the ready accessibility of new molecular techniques. While most of these new results have apparently confirmed the monoclonal origin of human epithelial (and other) tumours, there are a significant number of studies in which this conclusion just cannot be made. Moreover, analysis of many articles show that the potential impact of such considerations as patch size and clonal evolution on determinations of clonality have largely been ignored, with the result that a number of these studies are confounded. However, the clonal architecture of preneoplastic lesions provide some interesting insights — many lesions which might have been hitherto regarded as hyperplasias are apparently clonal in derivation. If this is indeed true, it calls into some question our hopeful corollary that a monoclonal origin presages a neoplastic habitus. Finally, it is clear, for many reasons, that methods of analysis which involve the disaggregation of tissues, albeit microdissected, are far from ideal and we should be putting more effort into techniques where the clonal architecture of normal tissues, preneoplastic and preinvasive lesions and their derivative tumours can be directly visualized in situ